Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis (Q41751139)

8 October 2017

1 reference

title

Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis (English)

1 reference

familial hemophagocytic lymphohistiocytosis

8 October 2017

main subject

0 references

3

Elinder G

1 reference

8 October 2017

Henter JI

1

1 reference

8 October 2017

Aricò M

series ordinal

2

1 reference

8 October 2017

Imashuku S

series ordinal

4

1 reference

8 October 2017

Janka G

series ordinal

5

1 reference

8 October 2017

publication date

1 April 1998

1 reference

Hematology / Oncology Clinics of North America

8 October 2017

published in

1 reference

8 October 2017

volume

12

1 reference

8 October 2017

issue

2

1 reference

8 October 2017

page(s)

417-433

1 reference

Neuropathology of familial erythrophagocytic lymphohistiocytosis: six cases and review of the literature

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16-213.

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Natural cytotoxicity impairment in familial haemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Cachectin (tumor necrosis factor): a macrophage hormone governing cellular metabolism and inflammatory response

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Abnormal T-cell phenotype in familial erythrophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Spontaneous NBT reduction by monocytes as a marker of disease activity in children with histiocytosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Hyperferritinemia in malignant histiocytosis, virus-associated hemophagocytic syndrome and familial erythrophagocytic lymphohistiocytosis. A survey of pediatric cases

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Familial haemophagocytic reticulosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Monokine expression in Langerhans' cell histiocytosis and sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease)

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Sinus histiocytosis with massive lymphadenopathy. Current status and future directions

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Hypercytokinemia in hemophagocytic syndrome

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Genetic analysis of familial erythrophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Lymphohistiocytosis: a multi-factorial syndrome of macrophagic activation clinico-pathological study of 38 cases

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Extranodal Rosai-Dorfman disease of the head and neck

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Familial hemophagocytic lymphohistiocytosis macrophages showing immunohistochemical properties of activated macrophages and T-accessory cells

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Cerebromeningeal haemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Familial hemophagocytic lymphohistiocytosis. Clinical review based on the findings in seven children

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Neuropathologic findings and neurologic symptoms in twenty-three children with hemophagocytic lymphohistiocytosis.

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Elevated circulating levels of interleukin-1 receptor antagonist but not IL-1 agonists in hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Lipoprotein alterations and plasma lipoprotein lipase reduction in familial hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Familial hemophagocytic lymphohistiocytosis and viral infections

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Successful induction with chemotherapy including teniposide in familial erythrophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Myelodysplastic syndrome following epipodophyllotoxin therapy in familial hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Unusual immunophenotype displayed by histiocytes in haemophagocytic lymphohistiocystosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Haemophagocytic lymphohistiocytosis: experience at two U.K. centres

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): response to methotrexate and mercaptopurine

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Central nervous system involvement in the erythrophagocytic disorders of infancy: the role of cerebrospinal fluid neopterins in their differential diagnosis and clinical management

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Serum Levels of Interferon-gamma, Cytotoxic Factor and Soluble Interleukin-2 Receptor in Childhood Hemophagocytic Syndromes.

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Familial hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Impaired natural killer activity and expression of interleukin-2 receptor antigen in familial erythrophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Immunodeficiency in familial erythrophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Partial engraftment of donor bone marrow cells associated with long-term remission of haemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Long-term survival in a patient with Rosai-Dorfman disease treated with interferon-alpha

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Hypofibrinogen and thrombocytopenia in familial hemophagocytic reticulosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Evidence for a polyclonal nature of the cell infiltrate in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease)

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Impaired natural killer activity in lymphohistiocytosis syndrome

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Bone marrow transplantation during fulminant EBV-infection in Duncan's syndrome

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

X-linked recessive progressive combined variable immunodeficiency (Duncan's disease)

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Osseous localization of Rosai-Dorfman disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Virus-associated hemophagocytic syndromeA benign histiocytic proliferation distinct from malignant histiocytosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Sinus histiocytosis with massive lymphadenopathy: A pseudolymphomatous benign disorder.Analysis of 34 cases

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Purely cutaneous Rosai-Dorfman disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Familial hemophagocytic lymphohistiocytosis in Israel. II. Pathologic findings

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Familial hemophagocytic lymphohistiocytosis (FHLH) in Israel. I. Description of 11 patients of Iranian-Iraqi origin and review of the literature

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Allogeneic Bone Marrow Transplantation for Familial Erythrophagocytic Lymphohistiocytosis, with High Dose VP16-Containing Conditioning Regimen

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

The Rosai-Dorfman disease histiocytes are not infected by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

Correction of Duncan's syndrome by allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70520-7

7 January 2021

10.1016/S0889-8588(05)70520-7

Identifiers

DOI

1 reference

release_habglnn4crc7dilgbhhfulxr3m

8 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/habglnn4crc7dilgbhhfulxr3m

24 November 2022

mapped directly with Wikidata item

1 reference